Incidental epidermodysplasia verruciformis human papillomavirus infection (EV acanthoma): evidence for ‘field cancerization’ and a putative cofactor in seborrheic keratosis
Angela Rohwedder, Henry Foong, Stephen K. Tyring, Peter Rady,
J. Andrew Carlson,
Peter Rady
Department of Immunology and Medical Microbiology, University of Texas Medical Branch, Houston, TX, USA
Search for more papers by this authorJ. Andrew Carlson
Divisions of Dermatology and Dermatopathology, Albany Medical College, Albany, NY, USAe-mail: [email protected]
Search for more papers by this authorAngela Rohwedder, Henry Foong, Stephen K. Tyring, Peter Rady,
J. Andrew Carlson,
Peter Rady
Department of Immunology and Medical Microbiology, University of Texas Medical Branch, Houston, TX, USA
Search for more papers by this authorJ. Andrew Carlson
Divisions of Dermatology and Dermatopathology, Albany Medical College, Albany, NY, USAe-mail: [email protected]
Search for more papers by this author
References
- 1 Antonsson A, Erfurt C, Hazard K, et al. Prevalence and type spectrum of human papillomaviruses in healthy skin samples collected in three continents. J Gen Virol 2003; 84: 1881.
- 2 Orth G. Human papillomaviruses associated with epidermodysplasia verruciformis in non-melanoma skin cancers: guilty or innocent? J Invest Dermatol 2005; 125: xii.
- 3 Rohwedder A, Slominski A, Wolff M, Kredentser D, Carlson JA. Epidermodysplasia verruciformis and cutaneous human papillomavirus DNA, but not genital human papillomavirus DNAs, are frequently detected in vulvar and vaginal melanoma. Am J Dermatopathol 2007; 29: 13.
- 4 Ambretti S, Venturoli S, Mirasoli M, et al. Assessment of the presence of mucosal human papillomaviruses in malignant melanomas using combined fluorescent in situ hybridization and chemiluminescent immunohistochemistry. Br J Dermatol 2007; 156: 38.
- 5 Rohwedder A, Philips B, Malfetano J, Kredentser D, Carlson JA. Vulvar malignant melanoma associated with human papillomavirus DNA: report of two cases and review of literature. Am J Dermatopathol 2002; 24: 230.
- 6 La Placa M, Ambretti S, Bonvicini F, et al. Presence of high-risk mucosal human papillomavirus genotypes in primary melanoma and in acquired dysplastic melanocytic naevi. Br J Dermatol 2005; 152: 909.
- 7 Ko CJ, Iftner T, Barr RJ, Binder SW. Changes of epidermodysplasia verruciformis in benign skin lesions: the EV acanthoma. J Cutan Pathol 2007; 34: 44.
- 8 Carlson JA, Scott D, Wharton J, Sell S. Incidental histopathologic patterns: possible evidence of ‘field cancerization’ surrounding skin tumors. Am J Dermatopathol 2001; 23: 494.
- 9 Orth G. Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol 2006; 18: 362.
- 10 Hayashi J, Matsui C, Mitsuishi T, Kawashima M, Morohashi M. Treatment of localized epidermodysplasia verruciformis with tacalcitol ointment. Int J Dermatol 2002; 41: 817.
- 11 Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 2002; 32: 579.
- 12 Laffort C, Le Deist F, Favre M, et al. Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency. Lancet 2004; 363: 2051.
- 13 Tobin E, Rohwedder A, Holland SM, Philips B, Carlson JA. Recurrent ‘sterile’ verrucous cyst abscesses and epidermodysplasia verruciformis-like eruption associated with idiopathic CD4 lymphopenia. Br J Dermatol 2003; 149: 627.
- 14 Doffinger R, Smahi A, Bessia C, et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 2001; 27: 277.
- 15 Berger TG, Sawchuk WS, Leonardi C, Langenberg A, Tappero J, Leboit PE. Epidermodysplasia verruciformis-associated papillomavirus infection complicating human immunodeficiency virus disease. Br J Dermatol 1991; 124: 79.
- 16 Barzegar C, Paul C, Saiag P, et al. Epidermodysplasia verruciformis-like eruption complicating human immunodeficiency virus infection. Br J Dermatol 1998; 139: 122.
- 17 Haas N, Fuchs PG, Hermes B, Henz BM. Remission of epidermodysplasia verruciformis-like skin eruption after highly active antiretroviral therapy in a human immunodeficiency virus-positive patient. Br J Dermatol 2001; 145: 669.
- 18 Davison SC, Francis N, McLean K, Bunker CB. Epidermodysplasia verruciformis-like eruption associated with HIV infection. Clin Exp Dermatol 2004; 29: 311.
- 19 Vermeer BJ, Bouwes Bavinck JN. Relevance of photo-immunosuppression for viral infections (i.e. human papilloma virus). Eur J Dermatol 1998; 8: 205.
- 20 Jablonska S, Orth G, Jarzabek-Chorzelska M, et al. Twenty-one years of follow-up studies of familial epidermodysplasia verruciformis. Dermatologica 1979; 158: 309.
- 21 Jablonska S, Majewski S. Epidermodysplasia verruciformis: immunological and clinical aspects. Curr Top Microbiol Immunol 1994; 186: 157.
- 22 Egawa K, Honda Y, Inaba Y, Ono T. Pigmented viral warts: a clinical and histopathological study including human papillomavirus typing. Br J Dermatol 1998; 138: 381.
- 23 Blessing K, McLaren KM, Maloney DJ, Porteus I, Hunter JA. Melanocytic proliferation in condylomata acuminata. A report of two cases and investigation by in situ hybridisation. Acta Derm Venereol 1989; 69: 238.
- 24 Baron JM, Rubben A, Grussendorf-Conen EI. HPV 18-induced pigmented bowenoid papulosis of the neck. J Am Acad Dermatol 1999; 40: 633.
- 25
Clavel CE,
Huu VP,
Durlach AP,
Birembaut PL,
Bernard PM,
Derancourt CG.
Mucosal oncogenic human papillomaviruses and extragenital Bowen disease.
Cancer
1999; 86: 282.
10.1002/(SICI)1097-0142(19990715)86:2<282::AID-CNCR12>3.0.CO;2-C CAS PubMed Web of Science® Google Scholar
- 26 Li J, Ackerman AB. “Seborrheic keratoses” that contain human papillomavirus are condylomata acuminata. Am J Dermatopathol 1994; 16: 398; discussion 6.
- 27 Roncalli de Oliveira W, Neto CF, Rady PL, Tyring SK. Seborrheic keratosis-like lesions in patients with epidermodysplasia verruciformis. J Dermatol 2003; 30: 48.
- 28 Jacyk WK, Dreyer L, De Villiers EM. Seborrheic keratoses of black patients with epidermodysplasia verruciformis contain human papillomavirus DNA. Am J Dermatopathol 1993; 15: 1.
- 29 De Oliveira WR, He Q, Rady PL, et al. HPV typing in Brazilian patients with epidermodysplasia verruciformis: high prevalence of EV-HPV 25. J Cutan Med Surg 2004.
- 30 Forslund O, Lindelof B, Hradil E, et al. High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in “Stripped” biopsies from the same tumors. J Invest Dermatol 2004; 123: 388.
- 31 Li YH, Chen G, Dong XP, Chen HD. Detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in nongenital seborrhoeic keratosis. Br J Dermatol 2004; 151: 1060.
- 32 Gushi A, Kanekura T, Kanzaki T, Eizuru Y. Detection and sequences of human papillomavirus DNA in nongenital seborrhoeic keratosis of immunopotent individuals. J Dermatol Sci 2003; 31: 143.
- 33 Assadoullina A, De Villiers EM, Bialasiewicz AA, Richard G. [Detection of human papillomavirus types in tumors and inflammations of the eye]. Klin Monatsbl Augenheilkd 1999; 215: 10.
- 34 Tsambaos D, Monastirli A, Kapranos N, et al. Detection of human papillomavirus DNA in nongenital seborrhoeic keratoses. Arch Dermatol Res 1995; 287: 612.
- 35 Zhu WY, Leonardi C, Penneys NS. Detection of human papillomavirus DNA in seborrheic keratosis by polymerase chain reaction. J Dermatol Sci 1992; 4: 166.
- 36 Zhao YK, Lin YX, Luo RY, et al. Human papillomavirus (HPV) infection in seborrheic keratosis. Am J Dermatopathol 1989; 11: 209.
- 37 Leonardi CL, Zhu WY, Kinsey WH, Penneys NS. Seborrheic keratoses from the genital region may contain human papillomavirus DNA. Arch Dermatol 1991; 127: 1203.
- 38 Soler C, Chardonnet Y, Euvrard S, Chignol MC, Thivolet J. Evaluation of human papillomavirus type 5 on frozen sections of multiple lesions from transplant recipients with in situ hybridization and non-isotopic probes. Dermatology 1992; 184: 248.
- 39 Lee ES, Whang MR, Kang WH. Absence of human papillomavirus DNA in nongenital seborrheic keratosis. J Korean Med Sci 2001; 16: 619.
- 40 Rohwedder A, Murphy M, Carlson JA. HPV in verruciform xanthoma – sensitivity and specificity of detection methods and multiplicity of HPV types affect results. J Cutan Pathol 2003; 30: 219; author reply 20.
- 41 Tomasini C, Aloi F, Pippione M. Seborrheic keratosis-like lesions in epidermodysplasia verruciformis. J Cutan Pathol 1993; 20: 237.
- 42 Sayag J, Muratore R, Olmer J, Hadida E. [Verriciform epidermodysplasia and malignant lymph node reticulosis]. Bull Soc Fr Dermatol Syphiligr 1966; 73: 313.
- 43 Schellander F, Fritsch P. [Epidermodysplasia verruciformis. New aspects of symptomatology and pathogenesis]. Dermatologica 1970; 140: 251.
- 44 Cascajo CD, Reichel M, Sanchez JL. Malignant neoplasms associated with seborrheic keratoses. An analysis of 54 cases. Am J Dermatopathol 1996; 18: 278.
- 45 Kwittken J. Squamous cell carcinoma arising in seborrheic keratosis. Mt Sinai J Med 1981; 48: 61.
- 46 Bloch PH. Transformation of seborrheic keratosis into Bowen’s disease. J Cutan Pathol 1978; 5: 361.
- 47 Monteagudo JC, Jorda E, Terencio C, Llombart-Bosch A. Squamous cell carcinoma in situ (Bowen’s disease) arising in seborrheic keratosis: three lesions in two patients. J Cutan Pathol 1989; 16: 348.
- 48 Yap WM, Tan PH, Ong BH. Malignancy arising in seborrheic keratosis: a report of two cases. Ann Acad Med Singapore 1997; 26: 235.
- 49 Rahbari H. Bowenoid transformation of seborrhoeic verrucae (keratoses). Br J Dermatol 1979; 101: 459.
- 50 Tieben LM, Berkhout RJ, Smits HL, et al. Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant skin lesions of renal transplant recipients. Br J Dermatol 1994; 131: 226.
- 51 Berkhout RJ, Bouwes Bavinck JN, Ter Schegget J. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 2000; 38: 2087.
- 52 De Jong-Tieben LM, Berkhout RJ, Smits HL, et al. High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 1995; 105: 367.
- 53 De Jong-Tieben LM, Berkhout RJ, Ter Schegget J, et al. The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: a clinical study to assess risk factors for keratotic skin lesions and skin cancer. Transplantation 2000; 69: 44.
- 54 Wieland U, Jurk S, Weissenborn S, Krieg T, Pfister H, Ritzkowsky A. Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol 2000; 115: 396.
- 55 Pfister H, Fuchs PG, Majewski S, Jablonska S, Pniewska I, Malejczyk M. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch Dermatol Res 2003; 295: 273.
- 56 Quereux G, N’Guyen JM, Dreno B. Human papillomavirus and extragenital in situ carcinoma. Dermatology 2004; 209: 40.
- 57 Purdie KJ, Surentheran T, Sterling JC, et al. Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J Invest Dermatol 2005; 125: 98.
- 58 Nowell PC. Tumor progression: a brief historical perspective. Semin Cancer Biol 2002; 12: 261.
- 59 Harwood CA, Surentheran T, Sasieni P, et al. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 2004; 150: 949.
- 60 Nuovo GJ, Ishag M. The histologic spectrum of epidermodysplasia verruciformis. Am J Surg Pathol 2000; 24: 1400.
- 61 Foong BBH, Ibrahimi OA, Elpern DJ, Tyring S, Rady P, Carlson JA. Multiple facial seborrheic keratosis-like lesions in a young woman with epidermodysplasia verrruciformis. Int J Dermatol 2007; in press.
Citing Literature
